Elsevier

Clinics in Perinatology

Volume 39, Issue 3, September 2012, Pages 543-562
Clinics in Perinatology

Weaning Infants from Mechanical Ventilation

https://doi.org/10.1016/j.clp.2012.06.003Get rights and content

Introduction

Mechanical ventilation (MV) is considered one of the major advances in neonatal medicine and is a widely used method of treatment, especially in the extremely preterm population. In a large cohort analysis of extremely low-birth-weight infants (ELBW) infants, 89% were treated with MV during the first day of life, and, almost 95% of survivors were invasively ventilated during their hospital stay.1 Recently, a multicenter randomized controlled trial (RCT) compared the use of noninvasive and invasive respiratory support immediately after birth and showed that 83% of the ELBW infants initially assigned to noninvasive support required endotracheal (ET) intubation and MV during hospitalization.2 In a large cohort of infants born at less than 28 weeks’ gestational age (GA), 74% were intubated and received surfactant therapy during their hospital stay.3 The Continuous Positive Airway Pressure or Intubation (COIN) trial included only infants between 25 and 28 weeks of GA with adequate respiratory efforts at birth. Nevertheless, 46% of the infants initially assigned to noninvasive support required ET intubation and MV.4 Thus, MV is a common therapy in neonatal intensive care units (NICUs), even in the current era of noninvasive respiratory support. Although MV offers essential support while the respiratory system recovers from acute failure and is necessary for survival, this therapy is associated with risks and complications, including mortality and neurodevelopmental impairments.1, 5 Therefore, when caring for extremely premature infants, clinicians should focus on weaning and removing MV as expeditiously as possible. Success of extubation is only 60% to 73% in ELBW infants.6, 7 Higher success rates (80%–86%) have been reported in some series that include all preterm infants.8, 9 Infants who fail and require reintubation, with its attendant risks, may experience deterioration of their respiratory status because of atelectasis. Episodes of hypoxemia or hypercapnia before reintubation may expose them to additional risks. Reintubation itself is unpleasant and may be traumatic and accompanied by bradycardia, hypercapnia, and alterations of cerebral blood flow and oxygenation.10, 11 On the other hand, many infants self-extubate and remain extubated subsequently.12 Those infants may therefore have been exposed to MV and potential ventilator-induced lung injury for longer than necessary. Protracted MV is not benign; in preterm baboons, 5 days of elective MV resulted in a greater degree of brain injury when compared with only 1 day.13 Using data from the National Institute of Child Health and Human Development Neonatal Research Network, Walsh and colleagues1 showed that each week of additional MV was associated with a significant increase in the likelihood of neurodevelopmental impairment. In addition, the ET tube (ETT) acts as a foreign body, quickly becoming colonized and acting as a portal of entry for pathogens, increasing the risk of ventilator-associated pneumonia and late-onset sepsis.14 Clearly, both premature extubation and unnecessarily prolonged MV are undesirable.

There is a striking paucity of good data to guide the clinician regarding optimal ways to wean respiratory support as well as to judge an infant's readiness for extubation. In this article, the available literature is summarized and reasonable evidence-based recommendations for expeditious weaning and extubation are formulated.

Section snippets

Reducing ventilator support

Weaning from MV is usually achieved by the gradual reduction of ventilatory support until the settings are judged to be low enough to remove support. Considerable controversy persists regarding the best ways to accomplish this goal, but some general evidence-based guidelines can be formulated.

Permissive Hypercapnia

Accepting higher levels of Paco2 during ventilation weaning to facilitate earlier extubation has been investigated extensively and is reviewed in detail elsewhere in this issue. Randomized clinical trials in preterm infants suggest that mild permissive hypercapnia is safe, but clinical benefits are modest.26 The safe limits of hypercapnia both during the first few days when the risk of intraventricular hemorrhage is highest and later on during the chronic phase of BPD have not been definitively

Extubation readiness

Failure of extubation is a common problem in extremely premature infants. Although neonatology has experienced major advances in MV and postextubation respiratory support, the science of determining if the patient is ready for extubation is still imprecise. Most preterm infants are easily extubated after a short period of MV but a few patients, for reasons such as respiratory muscle weakness, airway abnormalities, presence of a hemodynamically significant patent ductus arteriosus, immature

Predictors of extubation readiness

Over the past decades, several studies have investigated prediction tools that could help neonatologists determine extubation readiness in neonates with the highest chances of success. Several of these studies were performed before routine or widespread use of antenatal steroids and surfactant. Also, postextubation management was different from current practice, with infants being extubated to a headbox with humidified oxygen or room air.8, 57, 58, 59 More recently, other predictors have been

CPAP Versus Oxyhood or Nasal Cannula

The use of CPAP after extubation in preterm infants is superior to extubation to headbox or oxyhood.80 The physiologic basis for this finding is the inability of the immature rib cage of the ELBW infant to maintain adequate functional residual capacity because of its excessive compliance/insufficient rigidity. In addition, after being intubated for some time, the infant's vocal cords are edematous, preventing effective grunting; a mechanism the preterm infant normally uses to maintain internal

Summary

Weaning and extubation from MV remain an inexact science. Available evidence strongly suggests that early extubation is desirable, but our ability to predict the point at which this can be accomplished safely in ELBW infants remains limited. Volume-targeted ventilation may accelerate weaning from MV. There is a strong evidence base for using caffeine and distending airway pressure after extubation. Other adjuncts to weaning and extubation are less well established. Improved tools for predicting

First page preview

First page preview
Click to open first page preview

References (102)

  • J.P. Praud et al.

    Laryngeal function and nasal ventilatory support in the neonatal period

    Paediatr Respir Rev

    (2006)
  • R.J. Couser et al.

    Effectiveness of dexamethasone in preventing extubation failure in preterm infants at increased risk for airway edema

    J Pediatr

    (1992)
  • Support Study Group of the Eunice Kennedy Shriver NICHD Neonatal Research Network et al.

    Early CPAP versus surfactant in extremely preterm infants

    N Engl J Med

    (2010)
  • B.J. Stoll et al.

    Neonatal outcomes of extremely preterm infants from the NICHD neonatal research network

    Pediatrics

    (2010)
  • C.J. Morley et al.

    Nasal CPAP or intubation at birth for very preterm infants

    N Engl J Med

    (2008)
  • B.M. Stefanescu et al.

    A randomized, controlled trial comparing two different continuous positive airway pressure systems for the successful extubation of extremely low birth weight infants

    Pediatrics

    (2003)
  • G. Vento et al.

    Spontaneous minute ventilation is a predictor of extubation failure in extremely-low-birth-weight infants

    J Matern Fetal Neonatal Med

    (2004)
  • G. Dimitriou et al.

    Prediction of extubation failure in preterm infants

    Arch Dis Child Fetal Neonatal Ed

    (2002)
  • G. Dimitriou et al.

    Prediction of extubation outcome in preterm infants by composite extubation indices

    Pediatr Crit Care Med

    (2011)
  • T.A. Marshall et al.

    Physiologic changes associated with endotracheal intubation in preterm infants

    Crit Care Med

    (1984)
  • V. Venkatesh et al.

    Endotracheal intubation in a neonatal population remains associated with a high risk of adverse events

    Eur J Pediatr

    (2011)
  • A. Veldman et al.

    Characteristics and outcome of unplanned extubation in ventilated preterm and term newborns on a neonatal intensive care unit

    Paediatr Anaesth

    (2006)
  • M. Loeliger et al.

    Cerebral outcomes in a preterm baboon model of early versus delayed nasal continuous positive airway pressure

    Pediatrics

    (2006)
  • A. Greenough et al.

    Synchronized mechanical ventilation for respiratory support in newborn infants

    Cochrane Database Syst Rev

    (2008)
  • H. Hummler et al.

    Influence of different methods of synchronized mechanical ventilation on ventilation, gas exchange, patient effort, and blood pressure fluctuations in premature neonates

    Pediatr Pulmonol

    (1996)
  • M. Kapasi et al.

    Effort and work of breathing in neonates during assisted patient-triggered ventilation

    Pediatr Crit Care Med

    (2001)
  • Z.C. Reyes et al.

    Randomized, controlled trial comparing synchronized intermittent mandatory ventilation and synchronized intermittent mandatory ventilation plus pressure support in preterm infants

    Pediatrics

    (2006)
  • D.S. Patel et al.

    Work of breathing and different levels of volume-targeted ventilation

    Pediatrics

    (2009)
  • K. Wheeler et al.

    Volume-targeted versus pressure-limited ventilation in the neonate

    Cochrane Database Syst Rev

    (2010)
  • M. Keszler et al.

    Evolution of tidal volume requirement during the first 3 weeks of life in infants <800 g ventilated with volume guarantee

    Arch Dis Child Fetal Neonatal Ed

    (2009)
  • V.K. Bhutani et al.

    Acquired tracheomegaly in very preterm neonates

    Am J Dis Child Fetal Neonatal Ed

    (1986)
  • R.H. Clark et al.

    Prospective randomized comparison of high-frequency oscillatory and conventional ventilation in respiratory distress syndrome

    Pediatrics

    (1992)
  • S.E. Courtney et al.

    High-frequency oscillatory ventilation versus conventional mechanical ventilation for very-low-birth-weight infants

    N Engl J Med

    (2002)
  • A.H. Johnson et al.

    High-frequency oscillatory ventilation for the prevention of chronic lung disease of prematurity

    N Engl J Med

    (2002)
  • L.M. Askie et al.

    Oxygen-saturation targets and outcomes in extremely preterm infants

    N Engl J Med

    (2003)
  • Supplemental Therapeutic Oxygen for Prethreshold Retinopathy of Prematurity (STOP-ROP), a randomized, controlled trial. I: Primary outcomes

    Pediatrics

    (2000)
  • B. Stenson et al.

    Increased 36 week survival with high oxygen saturation target in extremely preterm infants

    Arch Dis Child Fetal Neonatal Ed

    (2011)
  • L.M. Askie et al.

    NeOProM: Neonatal Oxygenation Prospective Meta-analysis collaboration study protocol

    BMC Pediatr

    (2011)
  • B. Schmidt et al.

    Caffeine therapy for apnea of prematurity

    N Engl J Med

    (2006)
  • P.G. Davis et al.

    Caffeine for apnea of prematurity trial: benefits may vary in subgroups

    J Pediatr

    (2010)
  • L.W. Doyle et al.

    Dexamethasone treatment in the first week of life for preventing bronchopulmonary dysplasia in preterm infants: a systematic review

    Neonatology

    (2010)
  • L.W. Doyle et al.

    Postnatal hydrocortisone for preventing or treating bronchopulmonary dysplasia in preterm infants: a systematic review

    Neonatology

    (2010)
  • H.L. Halliday et al.

    Late (>7 days) postnatal corticosteroids for chronic lung disease in preterm infants

    Cochrane Database Syst Rev

    (2009)
  • L.W. Doyle et al.

    Impact of postnatal systemic corticosteroids on mortality and cerebral palsy in preterm infants: effect modification by risk for chronic lung disease

    Pediatrics

    (2005)
  • A. Stewart et al.

    Diuretics for respiratory distress syndrome in preterm infants

    Cochrane Database Syst Rev

    (2011)
  • L.P. Brion et al.

    Aerosolized diuretics for preterm infants with (or developing) chronic lung disease

    Cochrane Database Syst Rev

    (2006)
  • A. Stewart et al.

    Diuretics acting on the distal renal tubule for preterm infants with (or developing) chronic lung disease

    Cochrane Database Syst Rev

    (2011)
  • L.P. Brion et al.

    Intravenous or enteral loop diuretics for preterm infants with (or developing) chronic lung disease

    Cochrane Database Syst Rev

    (2000)
  • J.L. Hough et al.

    Chest physiotherapy for reducing respiratory morbidity in infants requiring ventilatory support

    Cochrane Database Syst Rev

    (2008)
  • G. Cresci et al.

    Nutrition support for the long-term ventilator-dependent patient

    Respir Care Clin North Am

    (2006)
  • Cited by (50)

    • Comparison the Effect of Breast Milk Smell, White Noise and Facilitated Tucking Applied to Turkish Preterm Infants During Endotracheal Suctioning on Pain and Physiological Parameters

      2021, Journal of Pediatric Nursing
      Citation Excerpt :

      Fifteen million preterm infants are born each year worldwide, and approximately 27% of these infants and 83%–95% of preterm infants with very low birth weight need mechanical ventilation (MV) support (Blencowe, Cousens, Chou, et al., 2013; Sant'Anna & Keszler, 2012; Silveira, Matijasevich, Horta, et al., 2013).

    • A randomized pilot study comparing the role of PEEP, O<inf>2</inf> flow, and high-flow air for weaning of ventilatory support in very low birth weight infants

      2018, Pediatrics and Neonatology
      Citation Excerpt :

      Nasal continuous positive airway pressure (NCPAP) therapy is used as a primary support modality for infants with respiratory distress syndrome and apnea of prematurity. It is also used as the key post-extubation respiratory support.1–3 Multiple studies have demonstrated that NCPAP is a safe treatment modality with no increase in short-term4–9 or long-term morbidities.10,11

    View all citing articles on Scopus

    Disclosure: The authors have nothing to disclose.

    View full text